China Shijiazhuang Pharmaceutical Group Overview
- Founded
-
1992
- Status
-
Public
- Employees
-
25,587
- Stock Symbol
-
01093
- Investments
-
12
- Share Price
-
$0.73
- (As of Monday Closing)
China Shijiazhuang Pharmaceutical Group General Information
Description
CSPC Pharmaceutical Group, or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio of generic drugs, bulk drugs, and drugs with improved formulations. Its R&D pipeline is focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.
Contact Information
- 226 Huanghe Road
- Shijiazhuang, Hebei 050035
- China
China Shijiazhuang Pharmaceutical Group Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.73 | $0.74 | $0.70 - $1.32 | 11.9B | 37.5M | $0.07 |
China Shijiazhuang Pharmaceutical Group Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 8,623,872 | 10,859,462 | 11,401,496 | 11,368,323 |
| Revenue | 4,515,779 | 4,593,766 | 4,315,708 | 3,610,307 |
| EBITDA | 1,249,167 | 1,167,244 | 1,029,041 | |
| Net Income | 875,940 | 904,500 | 868,068 | 746,844 |
| Total Assets | 6,020,739 | 6,054,205 | 5,450,428 | 4,602,606 |
| Total Debt | 57,248 | 84,435 | 14,754 | 48,477 |
China Shijiazhuang Pharmaceutical Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
China Shijiazhuang Pharmaceutical Group Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Dongchen Cai | Chairman & Chief Executive Officer | ||
| Cai Dongchen | Chairman, Executive Director & Chairman of the Nomination Committee |
China Shijiazhuang Pharmaceutical Group Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 00000000 | China Shijiazhuang Pharmaceutical Group | Chairman, Executive Director & Chairman of the Nomination Committee | 000 0000 |
| 00000 000 000 | Self | Board Member | 000 0000 |
| 0000 0000 00 | China Shijiazhuang Pharmaceutical Group | Board Member | 000 0000 |
| 00000000 000 | China Shijiazhuang Pharmaceutical Group | Chairman & Chief Executive Officer | 000 0000 |
China Shijiazhuang Pharmaceutical Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
China Shijiazhuang Pharmaceutical Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
China Shijiazhuang Pharmaceutical Group Investments & Acquisitions (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 22-Feb-2022 | 00 0000000 | 00.00 | Medical Supplies | |
| 000000000 000 | 08-Feb-2022 | 0000000000 | 000.00 | Drug Discovery | 000 00000 |
| 000000 000000 | 08-Jul-2021 | 000 | 00000 | Drug Discovery | |
| 00000 0000000 | 24-Jul-2020 | 00000 0000 | 00000 | Drug Discovery | |
| Haihe Biopharma | 11-Feb-2019 | Later Stage VC | 00000 | Drug Discovery |
China Shijiazhuang Pharmaceutical Group Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000000 00000000 | Drug Discovery | Guangzhou, China | 0000 |
China Shijiazhuang Pharmaceutical Group ESG
Risk Overview
Risk Rating
Updated April, 07, 2023
33.97 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,491
Rank
Percentile
Pharmaceuticals
Industry
00 of 871
Rank
Percentile
Pharmaceuticals
Subindustry
00 of 415
Rank
Percentile
China Shijiazhuang Pharmaceutical Group Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 0000000000 00 | 13-Oct-2017 | 000000000 00000000 | 00.000 | Completed |
|